Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia
The DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–233 of 233
On the TRAIL of a new therapy for leukemia
Kaufmann, S. H., & Steensma, D. P. (2005) · Leukemia · doi:10.1038/sj.leu.2403946 · Cited by 61
Oncogenic protein tyrosine kinases
Naoe, T., & Kiyoi, H. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4274-x · Cited by 61
Kubota, Y., Ohnishi, H., Kitanaka, A., Ishida, T., & Tanaka, T. (2004) · Leukemia · doi:10.1038/sj.leu.2403402 · Cited by 60
Signaling Pathways: The Benefits of Good Communication
Fisher, T. L., & White, M. F. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.024 · Cited by 60
Phosphoinositide 3‐kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells
Tabellini, G., Cappellini, A., Tazzari, P. L., Falà, F., Billi, A. M., Manzoli, L., Cocco, L., & Martelli, A. M. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20153 · Cited by 60
Self-citationWorkman, P. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0593-0 · Cited by 59
Tonks, A. J., Tonks, A. J., Pearn, L., Pearce, L., Hoy, T. G., Couzens, S., Fisher, J., Burnett, A. K., & Darley, R. L. (2004) · Leukemia · doi:10.1038/sj.leu.2403396 · Cited by 58
Proapoptotic Activity of Cell-Permeable Anti-Akt Single-Chain Antibodies
Shin, I., Edl, J., Biswas, S., Lin, P. C., Mernaugh, R. L., & Arteaga, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2898 · Cited by 55
In Vivo Molecular Pharmacology and Antitumor Activity of the Targeted Akt Inhibitor PX-316
Meuillet, E. J., Ihle, N. T., Baker, A. F., Gard, J. M. C., Stamper, C., Williams, R. R., Coon, A., Mahadevan, D., George, B. L., Kirkpatrick, L., et al. (2004) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/0965040042380487 · Cited by 54
Olesen, L. H., Aggerholm, A., Andersen, B. L., Nyvold, C. G., Guldberg, P., Nørgaard, J. M., & Hokland, P. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05791.x · Cited by 50
Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry
Tazzari, P. L., Cappellini, A., Grafone, T., Mantovani, I., Ricci, F., Billi, A. M., Ottaviani, E., Conte, R., Martinelli, G., & Martelli, A. M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05121.x · Cited by 46
Self-citationGills, J. J., & Dennis, P. A. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.7.787 · Cited by 46
Tabellini, G., Tazzari, P. L., Bortul, R., Evangelisti, C., Billi, A. M., Grafone, T., Martinelli, G., Baccarani, M., & Martelli, A. M. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05679.x · Cited by 45
Self-citationTherapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia
Morgan, M. A., Ganser, A., & Reuter, C. W. (2003) · Leukemia · doi:10.1038/sj.leu.2403024 · Cited by 44
PIKE/nuclear PI 3‐kinase signaling in preventing programmed cell death
Ye, K. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20549 · Cited by 42
Blocking the PI3K/PKB Pathway in Tumor Cells
Stauffer, F., Holzer, P. D., & Garcı́a-Echeverrı́a, C. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011054866937 · Cited by 39
Cheong, J., Eom, J.-I., Maeng, H. M., Lee, S., Hahn, J. S., Ko, Y. W., & Min, Y. H. (2003) · Leukemia Research · doi:10.1016/s0145-2126(03)00102-4 · Cited by 38
Martelli, A. M., Tabellini, G., Bortul, R., Tazzari, P. L., Cappellini, A., Billi, A. M., & Cocco, L. (2005) · PubMed · doi:10.14670/hh-20.239 · Cited by 36
Self-citationRizzo, M. G., Giombini, E., Diverio, D., Vignetti, M., Sacchi, A., Testa, U., Lo‐Coco, F., & Blandino, G. (2004) · Leukemia · doi:10.1038/sj.leu.2403483 · Cited by 34
Yu, W., Rao, Q., Wang, M., Tian, Z., Lin, D., Liu, X., & Wang, J. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.08.028 · Cited by 34
Wakabayashi, M., Miwa, H., Shikami, M., Hiramatsu, A., Ikai, T., Tajima, E., Yamamoto, H., Miura, K., Satoh, A., Itoh, M., et al. (2004) · The Hematology Journal · doi:10.1038/sj.thj.6200410 · Cited by 32
Flow cytometric detection of total and serine 473 phosphorylated Akt
Tazzari, P. L., Cappellini, A., Bortul, R., Ricci, F., Billi, A. M., Tabellini, G., Conte, R., & Martelli, A. M. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10262 · Cited by 30
Self-citationPhosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive gene
Barnache, S., Scolan, E. L., Kosmider, O., Denis, N., & Moreau-Gachelin, F. (2005) · Oncogene · doi:10.1038/sj.onc.1209187 · Cited by 29
Cai, D., Wang, Y., Ottmann, O. G., Barth, P. J., Neubauer, A., & Burchert, A. (2005) · Blood · doi:10.1182/blood-2005-08-3317 · Cited by 27
Bousquet, M., Récher, C., Quelen, C., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05784.x · Cited by 27
Gatekeeper pathways and cellular background in the pathogenesis and therapy of AML
Cammenga, J. (2005) · Leukemia · doi:10.1038/sj.leu.2403894 · Cited by 26
STI 571 inhibition effect on KITAsn822Lys-mediated signal transduction cascade
Beghini, A., Bellini, M., Magnani, I., Colapietro, P., Cairoli, R., Morra, E., & Larizza, L. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.03.007 · Cited by 25
Cornillet‐Lefèbvre, P., Cuccuini, W., Bardet, V., Tamburini, J., Gillot, L., Ifrah, N., Nguyên, P., Dreyfus, F., Mayeux, P., Lacombe, C., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2404054 · Cited by 25
Tabellini, G., Tazzari, P. L., Bortul, R., Billi, A. M., Conte, R., Manzoli, L., Cocco, L., & Martelli, A. M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05073.x · Cited by 24
Self-citationArsenic Trioxide for the Treatment of Acute Promyelocytic Leukemia
Lam, M. S., & Ignoffo, R. J. (2001) · Cancer Practice · doi:10.1046/j.1523-5394.2001.009003155.x · Cited by 24
Young, S. M., Cambareri, A. C., & Ashman, L. K. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.06.005 · Cited by 19
O’Gorman, D. M., McKenna, S. L., McGahon, A. J., & Cotter, T. G. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00024-8 · Cited by 15
Kornblau, S. M., Womble, M., Cade, J. S., Lemker, E., & Qiu, Y. (2005) · Leukemia · doi:10.1038/sj.leu.2403845 · Cited by 14
Cited by
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.001 · Cited by 2,284
Self-citationDubrovska, A., Kim, S., Salamone, R. J., Walker, J. R., Maira, S.-M., García-Echeverría, C., Schultz, P. G., & Reddy, V. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810956106 · Cited by 564
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
Steelman, L. S., Abrams, S. L., Whelan, J., Bertrand, F. E., Ludwig, D. E., Bäsecke, J., Libra, M., Stivala, F., Milella, M., Tafuri, A., et al. (2008) · Leukemia · doi:10.1038/leu.2008.26 · Cited by 385
Self-citationContribution of bone microenvironment to leukemogenesis and leukemia progression
Ayala, F., Dewar, R., Kieran, M., & Kalluri, R. (2009) · Leukemia · doi:10.1038/leu.2009.175 · Cited by 273
Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice
Kharas, M. G., Okabe, R., Ganis, J. J., Gozo, M., Khandan, T., Paktinat, M., Gilliland, D. G., & Gritsman, K. (2010) · Blood · doi:10.1182/blood-2009-06-229443 · Cited by 272
Metadata
- Authors
- Martelli, A. M., Nyåkern, M., Tabellini, G., Bortul, R., Tazzari, P. L., Evangelisti, C., & Cocco, L.
- Venue
- Leukemia
- Published
- 2006-04-27
- Volume
- 20
- Issue
- 6
- Pages
- 911-928
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W1974300980
- Cited by
- 342
- References
- 233
- FWCI
- 12.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.